- Report
- June 2025
- 50 Pages
Global
From €2394EUR$2,650USD£2,047GBP
- Report
- June 2025
- 50 Pages
Global
From €2394EUR$2,650USD£2,047GBP
Ketobemidone is an opioid analgesic used to treat moderate to severe pain. It is a synthetic opioid, derived from thebaine, and is structurally related to pethidine and other opioids. It is available in both oral and injectable forms, and is commonly used in combination with other analgesics. Ketobemidone is known to have a rapid onset of action and a short duration of action, making it suitable for the treatment of acute pain. It is also used in the management of chronic pain, such as cancer pain, and is sometimes used in combination with other analgesics.
Ketobemidone is available in many countries, including the United States, Canada, the United Kingdom, and Australia. It is marketed under various brand names, including Ketogan, Ketalar, and Ketanest.
Some companies in the Ketobemidone market include Pfizer, Mylan, and Sandoz. Show Less Read more